source
- STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvalsPrediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.STAT · 14d ago↗ source
- STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckleyEli Lilly is buying the psychedelics-focused biotech AtaiBeckley for $2.8 billion upfront, a move that will expand its neuroscience pipeline.STAT · 14d ago↗ source
- STAT+: Spring forward forever? Another daylight saving debate arrives in CongressTrump's pandemic preparedness nominee testifies, the "fang-to-pharmacy" pipeline, and more health news from Morning RoundsSTAT · 14d ago↗ source